FundedIQ
Biotechnology

Biostate AI: Funding, Investors & Team (Oct 2026)

Biostate AI aims to create generative AI that can positively impact human health. We recognize that biological entities are constantly changing, with each person exhibiting slight variations from day to day. Get a discounted promotional RNAseq service for academia worth $10,000, now available for just $6,000.

www.biostate.ai LinkedIn Palo Alto, United States 11-50 employees
Total raised
$12.0M
Rounds
2
Latest
Series A
May 2025

Biostate AI has raised $12.0M across 2 funding rounds on record, the most recent a Series A of $12.0M announced in May 2025.

That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Biostate AI Company Profile and Key Stats

Total funding raised
$12.0M
across 2 rounds on record
Funding rounds on record
2
1 with no disclosed amount
Latest funding round
Series A
$12.0M in May 2025
Employees
11-50
reported band
Headquarters
Palo Alto, United States

Latest funding round on record: May 2025.

Biostate AI Funding Rounds

Date
Round
Amount
Series A
$12.0M
Series A
Undisclosed

1 of 2 rounds was announced without a disclosed amount and is excluded from the total.

Biostate AI announced a Series A in Dec 2024; the amount was not disclosed.

5 months later, a Series A of $12.0M was announced in May 2025.

Biostate AI Founders and Leadership Team

Name
Role
Contact
David Zhang
Founder
Locked

Contact details for the Biostate AI team: 1 of 1 has an email address on file.

Start 14-day free trial →

Biostate AI Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.4M
30,319
$7.7M
8,591
$15M

Biostate AI's latest round of $12.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Biostate AI in Biotechnology and Palo Alto

Companies Similar to Biostate AI

Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…

Series B $50.0M

Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…

Series A $37.0M
Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Biostate AI Funding FAQs

What does Biostate AI do?

Biostate AI aims to create generative AI that can positively impact human health. We recognize that biological entities are constantly changing, with each person exhibiting slight variations from day to day. Get a discounted promotional RNAseq service for academia worth $10,000, now available for just $6,000.

How much funding has Biostate AI raised?

Biostate AI has raised $12.0M across 2 rounds on record. The most recent is a Series A of $12.0M announced in May 2025.

When did Biostate AI last raise funding?

Biostate AI's most recent funding round on record is a Series A of $12.0M, announced in May 2025.

Who founded Biostate AI?

FundedIQ lists David Zhang (Founder) at Biostate AI.

Where is Biostate AI headquartered?

Biostate AI is based in Palo Alto, California, United States.

How many employees does Biostate AI have?

Biostate AI is in the 11-50 employee band.

How does Biostate AI's funding compare to other Biotechnology startups?

Biostate AI's latest round of $12.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Biostate AI Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Biostate AI is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.